<DOC>
	<DOCNO>NCT00420394</DOCNO>
	<brief_summary>Rationale : Adjuvant chemoradiation consider standard care curative surgery adenocarcinoma stomach gastroesophageal cancer . Preoperative chemotherapy locally advance gastric cancer result significant tumoral downstaging improved rate curative resection . Purpose : To evaluate feasibility safety combination preoperative chemotherapy postoperative chemoradiation locally advance adenocarcinoma stomach gastroesophageal cancer</brief_summary>
	<brief_title>Perioperative Chemoradiotherapy Potentially Resectable Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Histologically confirm primary adenocarcinoma , poorly differentiate carcinoma , carcinoma otherwise specify , stomach gastroesophageal junction . 2 . T24 N03 M0 . T1 tumor eligible T1N13 3 . Disease must clinically limited stomach GEJ . 4 . Pretreatment PortaCath insertion obligatory 5 . No prior chemotherapy . 6 . No prior radiotherapy . 7 . Patients must surgical candidate determine treat surgeon . 8 . Adequate organ function define : 9 . Patients must ECOG Performance Status &lt; 1 . 10 . Patients must able sign inform consent document . 1 . Tis ( insitu carcinoma ) tumor determine TIN0 follow endoscopy , endoscopic ultrasound CT scanning . 2 . Patients primary carcinomas esophagus . 3 . Prior chest upper abdomen radiotherapy , prior systemic chemotherapy within past 5 year , prior esophageal gastric surgery . 4 . Patients evidence metastatic disease eligible . 5 . New York Heart Association Class III IV heart disease . 6 . Severe comorbid condition nonmalignant illness whose control may jeopardize complication study treatment . 7 . Pregnant lactate woman men unable unwilling practice contraception exclude . 8 . Any history prior malignancy ( nonmelanoma skin cancer , insitu cervical cancer , superficial transitional cell bladder cancer ) . 9 . Clinically significant hearing loss . 10 . Patients history seizure disorder receive phenytoin , phenobarbital , antiepileptic medication . 11 . Patients fully comprehend therapeutic implication protocol comply requirement . 12 . Patients medical psychiatric condition disease , investigator â€™ judgment , would make patient inappropriate entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Adjuvant chemoradiotherapy</keyword>
	<keyword>Adenocarcinoma stomach gastroesophageal junction</keyword>
</DOC>